|
Stage Information
TNM definitions
AJCC stage groupings
Localized resectable adult primary liver cancer
Localized and locally advanced unresectable adult primary liver cancer
Advanced adult primary liver cancer
The American Joint Committee on Cancer (AJCC) has designated TNM stages for liver cancer as follows:[1]
TNM definitions
Primary tumor (T)
TX: Primary tumor cannot be assessed
T0: No evidence of primary tumor
T1: Solitary tumor without vascular invasion
T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
T3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s)
T4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of the visceral peritoneum
Regional lymph nodes (N)
NX: Regional lymph nodes cannot be assessed
N0: No regional lymph node metastasis
N1: Regional lymph node metastasis
[Note: The regional lymph nodes are the hilar (i.e., those in the hepatoduodenal ligament, hepatic and periportal nodes). Regional lymph nodes also include those along the inferior vena cava, hepatic artery, and portal vein. Any lymph node involvement beyond these nodes is considered distant metastasis and should be coded as M1. Involvement of the inferior phrenic lymph nodes should also be considered M1.]
Distant metastasis (M)
MX: Distant metastasis cannot be assessed
M0: No distant metastasis
M1: Distant metastasis
[Note: Metastases occur most frequently in bones and lungs. Tumors may extend through the capsule to adjacent organs (adrenal glands, diaphragm, and colon) or may rupture, causing acute hemorrhage and peritoneal carcinomatosis.]
The T classification is based on the results of multivariate analyses of factors affecting prognosis after resection of liver carcinomas. The classification considers the presence or absence of vascular invasion (as assessed radiographically or pathologically), the number of tumor nodules (single vs multiple), and the size of the largest tumor (≤5 cm vs >5 cm). For pathologic classification, vascular invasion includes gross as well as microscopic involvement of vessels. Major vascular invasion (T3) is defined as invasion of the branches of the main portal vein (right or left portal vein, this does not include sectoral or segmental branches) or as invasion of one or more of the 3 hepatic veins (right, middle, or left). Multiple tumors include satellitosis, multifocal tumors, and intrahepatic metastases. Invasion of adjacent organs other than the gallbladder or with perforation of the visceral peritoneum is considered T4.
AJCC stage groupings
Stage I
T1, N0, M0
Stage II
T2, N0, M0
Stage IIIA
T3, N0, M0
Stage IIIB
T4, N0, M0
Stage IIIC
Any T, N1, M0
Stage IV
Any T, any N, M1
For purposes of treatment, patients with liver cancer are grouped into 1 of 3 groups: localized resectable, localized unresectable, or advanced disease. These groups are described with the following AJCC stage groupings:
Localized resectable adult primary liver cancer
(T1 and T2; N0; M0)
Localized resectable liver cancer is confined to a solitary mass in a portion of the liver that allows the possibility of complete surgical removal of the tumor with a margin of normal liver. Liver function tests are usually normal or minimally abnormal, and there should be no evidence of cirrhosis beyond Child class A or chronic hepatitis. Only a small percentage of liver cancer patients will prove to have such localized resectable disease. Preoperative assessment that includes helical computed tomography and/or magnetic resonance scanning should be directed toward determining the presence of extension of tumor across interlobar planes, involvement of the hepatic hilus, or encroachment on the vena cava. A resected specimen should contain a 1- to 2-cm margin of normal liver. Patients with chronic hepatitis and cirrhosis are at high risk when surgical resection is performed.
Localized and locally advanced unresectable adult primary liver cancer
(Selected T1, T2, T3, and T4; N0; M0)
Localized and locally advanced unresectable liver cancer appears to be confined to the liver, but surgical resection of the entire tumor is not possible despite a localized mass because of location within the liver or concomitant medical conditions (such as cirrhosis). These patients may be considered for liver transplantation.[2-5] For other patients, chemoembolization, percutaneous ethanol injection, or radiofrequency ablation (when fewer than 4 lesions are present) may be options.[6]
Advanced adult primary liver cancer
(Any T, N1 or M1)
Advanced liver cancer is present in both lobes of the liver or has metastasized to distant sites. Median survival is usually 2 to 4 months. The most common metastatic sites of hepatocellular cancer are the lungs and bone. Multifocal disease in the liver is common, particularly when cirrhosis or chronic hepatitis is present. Chemoembolization has been beneficial in selected patients who have no extrahepatic metastases.[6]
References
Liver (including intrahepatic bile ducts). In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002, pp 131-8.
Farmer DG, Rosove MH, Shaked A, et al.: Current treatment modalities for hepatocellular carcinoma. Ann Surg 219 (3): 236-47, 1994. [PUBMED Abstract]
Ringe B, Wittekind C, Weimann A, et al.: Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 175 (4): 299-305, 1992. [PUBMED Abstract]
Venook AP: Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 12 (6): 1323-34, 1994. [PUBMED Abstract]
Iwatsuki S, Starzl TE, Sheahan DG, et al.: Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214 (3): 221-8; discussion 228-9, 1991. [PUBMED Abstract]
Tanaka K, Nakamura S, Numata K, et al.: The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 82 (1): 78-85, 1998. [PUBMED Abstract]
http://www.cancer.gov/cancertopics/pdq/treatment/adult-primary-liver/HealthProfessional/page3
|
